Call for Abstract
Scientific Program
30th World Conference on Gastroenterology & Hepatology, will be organized around the theme “"Therapeutic Advances in Liver Disease: Novel Approaches and Future Directions"”
Gastroenterology-2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Gastroenterology-2024
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Researchers are invited to submit their abstracts for the "Precision Medicine in Gastrointestinal Cancers" track at GASTROENTEROLOGY-2024. This track will focus on pioneering personalized approaches to the treatment of gastrointestinal cancers, including colorectal, pancreatic, liver, and gastric cancers. Topics of interest include, but are not limited to:
- Advances in molecular profiling and genetic testing.
- Novel biomarker discovery and validation.
- Development and clinical implementation of targeted therapies.
- Multi-omics integration for refined cancer diagnostics.
- Innovative strategies for early cancer detection and prognosis.
Attendees can expect to engage with cutting-edge research, learn about the latest technological advancements, and discuss the clinical applications of precision medicine. This track offers a comprehensive overview of how personalized medicine is transforming the landscape of gastrointestinal cancer care, presenting both challenges and opportunities. Presentations will highlight real-world case studies, breakthrough research, and collaborative efforts aimed at improving patient outcomes through tailored therapeutic strategies.
Researchers are encouraged to submit their abstracts for the "Gut Microbiota and Digestive Health" track at GASTROENTEROLOGY-2024. This track will explore the crucial role of the gut microbiota in maintaining digestive health and its implications in gastrointestinal diseases. Topics of interest include, but are not limited to:
- The impact of gut microbiota on digestive physiology and immune function.
- Microbiome alterations in gastrointestinal diseases such as IBD, IBS, and colorectal cancer.
- Probiotics, prebiotics, and dietary interventions to modulate gut microbiota.
- Advances in microbiome analysis and therapeutic applications.
- Interactions between gut microbiota and host genetics.
Attendees can expect to gain a comprehensive understanding of the dynamic relationship between the gut microbiota and digestive health. This track will feature presentations on the latest research, innovative methodologies, and clinical applications aimed at harnessing the microbiome for disease prevention and treatment. Experts will share insights into the mechanisms by which gut microbiota influence health, present novel therapeutic strategies, and discuss the future directions of microbiome research in gastroenterology.
Researchers are invited to submit their abstracts for the "Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)" track at GASTROENTEROLOGY-2024. This track will focus on the latest advancements in understanding, diagnosing, and treating NAFLD and NASH. Topics of interest include, but are not limited to:
- Pathophysiology and molecular mechanisms underlying NAFLD and NASH.
- Advances in non-invasive diagnostic tools and biomarkers.
- Innovative therapeutic strategies and clinical trials.
- Epidemiological trends and risk factors.
- The role of lifestyle interventions and comorbidities management.
Attendees can expect to delve into comprehensive discussions on the significant burden of NAFLD and NASH on global health. This track will feature expert presentations on groundbreaking research, emerging treatments, and clinical best practices. Participants will gain insights into the latest diagnostic techniques, explore novel therapeutic approaches, and understand the interplay between metabolic disorders and liver health. This track aims to foster collaboration and knowledge exchange to address the growing challenge of NAFLD and NASH in clinical practice.
Researchers are invited to submit their abstracts for the "Hepatocellular Carcinoma (HCC)" track at GASTROENTEROLOGY-2024. This track will cover the latest advancements in the understanding, diagnosis, and treatment of HCC. Topics of interest include, but are not limited to:
- Molecular and genetic insights into HCC pathogenesis.
- Novel biomarkers for early detection and prognosis.
- Advances in imaging techniques and diagnostic tools.
- Emerging systemic therapies and combination treatments.
- Strategies for prevention and risk factor modification.
Attendees can expect to gain a deep understanding of the complex biology of HCC and the latest innovations in its clinical management. This track will feature presentations on cutting-edge research, including the identification of new therapeutic targets and the development of personalized treatment regimens. Experts will discuss advancements in early detection methods, the impact of novel systemic therapies, and the integration of multidisciplinary approaches in managing HCC. The track aims to facilitate knowledge exchange and foster collaborations to improve outcomes for patients with HCC.
Recent advancements in microbiome research have unveiled profound implications for liver health. The intricate interplay between gut microbiota and liver function is increasingly recognized as pivotal in both health and disease. This track at GASTROENTEROLOGY-2024 aims to explore the latest findings in microbiome science as it relates to liver diseases, spanning from non-alcoholic fatty liver disease (NAFLD) to cirrhosis and hepatocellular carcinoma.
Key Topics:
- Microbiota Composition and Liver Diseases: Insights into how gut microbial communities influence liver pathology.
- Therapeutic Interventions: Novel microbiome-based approaches for managing liver disorders.
- Role of Diet and Lifestyle: Impact of dietary habits and lifestyle on microbiome composition and liver health.
- Technological Advances: Cutting-edge methodologies in microbiome research and their application in liver disease.
Attendees Can Expect: Attendees will gain comprehensive insights into the latest research linking microbiome dynamics with liver health. From mechanistic understandings to clinical implications, this track promises to illuminate new avenues for therapeutic strategies and public health interventions aimed at optimizing liver function through microbiome modulation.
Researchers are invited to submit abstracts for the "Liver Transplantation and Regenerative Medicine" track at GASTROENTEROLOGY-2024. This track will showcase groundbreaking research in liver transplantation, regenerative medicine approaches, and innovative therapies aimed at improving outcomes for patients with liver diseases.
Abstract submissions should focus on advancements in liver transplant techniques, including donor selection criteria, surgical innovations, immunosuppressive strategies, and post-transplant care protocols. Additionally, we welcome research on regenerative medicine techniques such as stem cell therapies, tissue engineering, and liver regeneration mechanisms.
What to Expect:
Attendees can expect in-depth sessions featuring state-of-the-art presentations, clinical case studies, and panel discussions led by renowned experts in the field. The track will explore emerging trends in personalized medicine, the role of biomarkers in predicting transplant outcomes, and ethical considerations in regenerative medicine.
Join us at GASTROENTEROLOGY-2024 to delve into the forefront of liver transplantation and regenerative medicine, and to contribute to shaping the future of liver disease management.
We invite researchers to submit abstracts for the "Hepatitis B and Hepatitis C" track at GASTROENTEROLOGY-2024. This track will focus on advancing our understanding and management of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, two major global health challenges.
Abstract submissions should highlight novel insights into viral pathogenesis, diagnostic innovations, treatment strategies, and outcomes in diverse patient populations. Topics of interest include antiviral therapies, immune modulation approaches, viral resistance mechanisms, and the impact of comorbidities on disease progression.
What to Expect:
Attendees can anticipate dynamic discussions featuring leading experts, comprehensive updates on recent clinical trials, and the latest guidelines for managing HBV and HCV infections. The track will address emerging therapeutic targets, vaccine development efforts, and public health initiatives aimed at reducing the global burden of viral hepatitis.
Join us at GASTROENTEROLOGY-2024 to contribute to the advancement of hepatitis research and to collaborate on strategies for optimizing patient care in this critical area of gastroenterology.
Researchers are invited to submit abstracts for the "Gastrointestinal Motility Disorders" track at GASTROENTEROLOGY-2024. This track will highlight advancements in understanding and managing disorders of gastrointestinal motility, encompassing a spectrum of conditions from dysphagia to colonic dysmotility.
Abstract submissions should focus on novel insights into pathophysiology, diagnostic techniques, therapeutic interventions, and outcomes assessment in patients with motility disorders. Topics of interest include neurogenic disorders, functional gastrointestinal disorders (FGIDs), gastroparesis, esophageal dysmotility, and innovative approaches such as biofeedback therapy and neuromodulation.
What to Expect:
Attendees can expect engaging sessions featuring expert-led presentations, clinical case discussions, and interactive workshops on the latest diagnostic tools and treatment modalities. The track will address current challenges in the field, advancements in motility testing, and personalized treatment strategies tailored to individual patient needs.
Join us at GASTROENTEROLOGY-2024 to explore cutting-edge research in gastrointestinal motility disorders and to collaborate with peers on improving clinical outcomes and quality of life for patients worldwide.
Researchers are invited to submit abstracts for the "Functional Gastrointestinal Disorders (FGIDs)" track at GASTROENTEROLOGY-2024. This track will focus on advancing our understanding and management of complex disorders characterized by gastrointestinal symptoms without identifiable structural or biochemical abnormalities.
Abstract submissions should address diverse aspects of FGIDs, including epidemiology, pathophysiology, diagnostic challenges, treatment strategies, and patient outcomes. We encourage submissions on irritable bowel syndrome (IBS), functional dyspepsia, functional abdominal pain syndromes, and other less common FGIDs.
What to Expect:
Attendees can expect comprehensive sessions featuring state-of-the-art presentations, clinical case discussions, and debates on controversial topics in FGID research and management. The track will explore emerging diagnostic criteria, novel therapeutic modalities, and the role of gut-brain interactions in symptom generation.
Join us at GASTROENTEROLOGY-2024 to collaborate with experts in the field, share groundbreaking research findings, and contribute to advancing the care of patients suffering from FGIDs through multidisciplinary approaches and personalized treatment strategies.
Researchers are invited to submit abstracts for the "Nutrition and Digestive Health" track at GASTROENTEROLOGY-2024. This track will explore the intricate relationship between nutrition and gastrointestinal function, focusing on the impact of dietary factors on digestive health and disease outcomes.
Abstract submissions should address a range of topics including dietary interventions in gastrointestinal disorders, nutritional management of chronic conditions, microbiome modulation through diet, and the role of nutritional supplements in promoting gut health.
What to Expect:
Attendees can expect informative sessions featuring expert presentations on the latest research findings, clinical trials, and dietary guidelines relevant to gastroenterology. The track will cover evidence-based approaches to nutritional assessment, personalized nutrition plans, and discussions on integrating nutrition into comprehensive patient care strategies.
Join us at GASTROENTEROLOGY-2024 to engage with leading researchers, exchange insights, and explore innovative strategies for optimizing digestive health through nutrition. This track aims to foster collaboration and advance knowledge in the field of nutritional gastroenterology.
Researchers are invited to submit abstracts for the "Gastrointestinal Oncology" track at GASTROENTEROLOGY-2024. This track will focus on recent advances in the diagnosis, treatment, and management of gastrointestinal (GI) cancers, encompassing a broad spectrum from esophageal to colorectal malignancies.
Abstract submissions should address innovative strategies in cancer screening, precision medicine approaches, multimodal treatment protocols, and survivorship care in GI oncology. We encourage submissions on biomarker-driven therapies, immunotherapy advancements, surgical innovations, and outcomes research.
What to Expect:
Attendees can expect dynamic sessions featuring leading experts presenting on the latest clinical trials, personalized treatment algorithms, and emerging technologies in GI oncology. The track will delve into multidisciplinary approaches to cancer care, including the integration of radiomics, genomic profiling, and patient-centered care models.
Join us at GASTROENTEROLOGY-2024 to collaborate on advancing the field of GI oncology through transformative research and innovative clinical practices. Engage in discussions that explore the future directions of cancer treatment and survivorship, aiming to improve outcomes and quality of life for patients globally.
Researchers are invited to submit abstracts for the "Liver Fibrosis and Cirrhosis" track at GASTROENTEROLOGY-2024. This track will focus on advancing our understanding and management of liver fibrosis and cirrhosis, critical stages in the progression of chronic liver diseases.
Abstract submissions should highlight novel insights into the pathophysiology of fibrosis, diagnostic innovations, prognostic markers, and therapeutic strategies aimed at preventing or reversing fibrosis progression. Topics of interest include non-invasive assessment techniques, biomarkers of fibrosis regression, personalized medicine approaches, and the impact of comorbidities on disease outcomes.
What to Expect:
Attendees can anticipate comprehensive sessions featuring expert presentations on the latest research findings, clinical trials, and therapeutic developments in liver fibrosis and cirrhosis. The track will explore emerging treatments such as antifibrotic therapies, liver transplantation advancements, and the role of lifestyle interventions in disease management.
Join us at GASTROENTEROLOGY-2024 to contribute to the dialogue on liver fibrosis and cirrhosis, collaborate with peers, and explore innovative strategies aimed at improving patient outcomes and quality of life.
Researchers are invited to submit abstracts for the "Pediatric Gastroenterology" track at GASTROENTEROLOGY-2024. This track will focus on advancing the understanding and management of gastrointestinal disorders in children, addressing a spectrum from common pediatric GI conditions to rare diseases.
Abstract submissions should highlight innovative research in pediatric gastroenterology, including diagnostic challenges, treatment outcomes, nutritional interventions, and psychosocial aspects of care. Topics of interest encompass inflammatory bowel disease (IBD), celiac disease, functional gastrointestinal disorders, and advancements in pediatric endoscopy and imaging.
What to Expect:
Attendees can expect enlightening sessions featuring expert presentations on pediatric GI pathophysiology, evidence-based treatment guidelines, and multidisciplinary approaches to care. The track will explore the latest research in microbiome science, genetic predispositions, and personalized medicine strategies tailored to pediatric patients.
Join us at GASTROENTEROLOGY-2024 to engage in discussions that shape the future of pediatric gastroenterology, collaborate with leaders in the field, and discover innovative approaches aimed at optimizing health outcomes for children with gastrointestinal disorders.
Researchers are invited to submit abstracts for the "Bariatric and Metabolic Surgery" track at GASTROENTEROLOGY-2024. This track will highlight recent advancements in surgical interventions for obesity and metabolic disorders, focusing on outcomes, complications, and long-term patient management.
Abstract submissions should cover various aspects of bariatric surgery, including novel techniques, perioperative care protocols, metabolic outcomes, and the impact on comorbidities such as diabetes and cardiovascular disease. We welcome studies on patient selection criteria, surgical innovations, and comparative effectiveness research.
What to Expect:
Attendees can expect comprehensive sessions featuring expert presentations on the latest advancements in bariatric and metabolic surgery. The track will explore emerging trends in minimally invasive techniques, revisional surgery options, and the role of gut microbiota in metabolic health.
Join us at GASTROENTEROLOGY-2024 to delve into discussions on optimizing patient outcomes, navigating post-surgical challenges, and integrating metabolic surgery into multidisciplinary care models. Engage with renowned surgeons and researchers to shape the future of bariatric surgery and metabolic medicine.
Researchers are invited to submit abstracts for the "Colorectal Cancer Screening and Surveillance" track at GASTROENTEROLOGY-2024. This track will focus on advancements in screening methodologies, surveillance strategies, and diagnostic technologies aimed at improving early detection and management of colorectal cancer.
Abstract submissions should address innovative approaches in colorectal cancer screening, including fecal occult blood tests (FOBT), colonoscopy advancements, virtual colonoscopy (CT colonography), and emerging biomarkers for early detection. We encourage submissions on surveillance protocols post-polypectomy, interval cancer rates, and quality indicators in screening programs.
What to Expect:
Attendees can expect insightful sessions featuring expert presentations on the latest research findings, clinical trials, and guidelines in colorectal cancer screening and surveillance. The track will explore the role of artificial intelligence in imaging interpretation, patient adherence to screening protocols, and population-based strategies to reduce disparities in screening rates.
Join us at GASTROENTEROLOGY-2024 to engage in discussions that shape the future of colorectal cancer prevention and early detection. Collaborate with leaders in the field, exchange ideas, and contribute to advancing evidence-based practices in colorectal cancer screening and surveillance.
Researchers are invited to submit abstracts for the "Artificial Intelligence and Digital Health in Gastroenterology" track at GASTROENTEROLOGY-2024. This track will explore the transformative impact of artificial intelligence (AI) and digital health technologies on the field of gastroenterology.
Abstract submissions should focus on AI applications in gastrointestinal imaging interpretation, predictive analytics for disease management, automated endoscopic quality assessment, and personalized treatment algorithms. We welcome studies on digital health innovations such as telemedicine platforms, mobile health apps, and wearable devices for remote patient monitoring.
What to Expect:
Attendees can expect enlightening sessions featuring expert presentations on the integration of AI into clinical practice, real-world applications of digital health tools, and regulatory considerations in AI-driven diagnostics. The track will explore collaborative efforts between gastroenterologists, data scientists, and technology developers to harness AI's potential in improving patient outcomes and operational efficiency.
Join us at GASTROENTEROLOGY-2024 to explore the frontier of AI and digital health in gastroenterology, engage in discussions on ethical implications and future trends, and contribute to shaping the digital transformation of gastroenterological care.
Researchers are invited to submit abstracts for the "Quality Improvement and Patient-Centered Care" track at GASTROENTEROLOGY-2024. This track will focus on initiatives and innovations aimed at enhancing quality of care, patient safety, and outcomes in gastroenterology.
Abstract submissions should address quality improvement projects, implementation of evidence-based practices, patient engagement strategies, and advancements in healthcare delivery models. Topics of interest include initiatives to reduce procedural complications, improve adherence to guidelines, optimize resource utilization, and enhance patient satisfaction.
What to Expect:
Attendees can expect informative sessions featuring expert presentations on successful quality improvement initiatives, case studies in patient-centered care, and strategies for fostering a culture of continuous improvement in gastroenterology practices. The track will explore metrics for measuring healthcare quality, innovations in patient communication technologies, and the integration of patient-reported outcomes in clinical decision-making.
Join us at GASTROENTEROLOGY-2024 to collaborate with peers, share best practices in quality improvement, and contribute to advancing patient-centered care in gastroenterology. Engage in discussions that address challenges, opportunities, and future directions in enhancing healthcare quality and patient outcomes.